Status:
RECRUITING
Combining High-frequency Micro-ultrasound and Multiparametric MRI Target Biopsy for Detecting Prostate Cancer
Lead Sponsor:
Salzburger Landeskliniken
Conditions:
Prostatic Neoplasm of Uncertain Behavior
Eligibility:
MALE
18-99 years
Phase:
NA
Brief Summary
\*\*Study Goal:\*\* The purpose of this clinical trial is to determine if combining high-frequency micro-ultrasound with multiparametric MRI biopsy and a systematic biopsy can better detect clinically...
Detailed Description
The primary objective of this study is (i) to demonstrate that the combination of highfrequency micro-ultrasound target biopsy, multiparametric MRI target biopsy, and systematic biopsy detects more cl...
Eligibility Criteria
Inclusion
- \- Men with suspected clinically significant prostate cancer, identified by the rise in PSA level, suspicious digital rectal examination or both and pathologic multiparametric MRI of the prostate (\>= PI-RADS III)
Exclusion
- Patients with histopathologic proven prostate cancer
- PSA \> 20 ng/ml
- Finding in digital rectal examination \>= cT2c
- Untreated bacterial infection of the prostate
- Untreated coagulopathy
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06579911
Start Date
November 1 2023
End Date
January 1 2026
Last Update
September 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uniklinikum Salzburg, Department for Urology and Andrology
Salzburg, Salzburg, Austria, 5020